Home > PJ (current issue) > News / Daily News | Search

The Pharmaceutical Journal
Vol 272 No 7282 p43-49
17 January 2004


News summary

DIARY   Branch meetings   Future Events   Conferences

43 Concerns raised with Privy Council over new Charter Eleven past-presidents and two former heads of the law department of the Royal Pharmaceutical Society have written to the Privy Council to express grave concerns about the Council's petition for a new Royal Charter ...more

43 Health department says wait before putting DIY NHS branding on community pharmacies Community pharmacists in England are being told by the Department of Health not to rush into spending money on NHS branding for their pharmacies ...more

44 Vitamin D supplements may protect against MS Women who take vitamin D supplements may have a lower risk of developing multiple sclerosis than women who do not take supplements, according to recent research ...more

44 Opinion divided at Boots over statin switch A survey of Boots pharmacists has revealed mixed opinions about the potential reclassification of simvastatin as a pharmacy medicine ...more

44 Antiviral drug reduces herpes transmission A person infected with herpes simplex type 2 (HSV-2) can reduce the risk of genital herpes transmission to their partner by taking a single daily dose of valaciclovir (Valtrex), results from a new study show ...more

44 Epilepsy drug for MS The antiepileptic drug levetiracetam (Keppra) may prove to be an effective treatment for controlling the symptoms of spasticity in patients with multiple sclerosis, say American researchers ...more

44 Low tar not safer The risk of dying from lung cancer is the same for smokers of very low tar cigarettes as it is for those smoking low and medium tar brands, a US study of almost one million people shows ...more

44 Tobacco control plan in Scotland An extra £4m is to be invested into smoking cessation plans launched this week in Scotland by deputy health minister Tom McCabe ...more

45 Trastuzumab fails to impress in lung cancer trial Trastuzumab (Herceptin) has failed to improve outcomes for patients with non-small-cell lung cancer, a study reveals ...more

45 DTB gives cautious welcome to second-line use of two newer antifungal agents ... but criticises transdermal contraceptive patch website ...more

45 Scotland rejects new drugs for cancer and Alzheimer's Use of pegylated liposomal doxorubicin (Caelyx) for metastatic breast cancer is not recommended for use within NHS Scotland, says the Scottish Medicines Consortium in guidance issued this week ...more

46 Guidance for brand name prescriptions updated Guidance on dispensing and endorsing prescriptions which bear both a brand and generic name for a product has been updated ...more

46 London pharmacists demand co-ordinated action after knife attacks on pharmacy staff Pharmacists in north-east London are demanding that action is taken to co-ordinate an appropriate response following knife attacks on pharmacy staff ...more

46 Boots to shed up to 1,000 jobs at Nottingham HQ The Boots Company is expected to announce that it is shedding up to 1,000 of the 3,000 jobs at its head office in Nottingham ...more

46 Errors on NPA malaria chart The National Pharmaceutical Association's blue information chart on malaria prophylaxis is being reprinted owing to an error on the original version ...more

46 NPA payroll service The National Pharmaceutical Association is offering its members a fully managed payroll service for their staff, in conjunction with Ceridian Centrefile ...more

46 PSNC funding guide The Pharmaceutical Services Negotiating Committee has updated its guide to sources of funding for community pharmacy ...more

46 Care records contracts Local contracts to run the NHS Care Records Service for the North West & West Midlands and Eastern regions of England have gone to CSC and Accenture, respectively ...more

46 Pfizer joins CoMedis Pfizer Pharmaceuticals has joined the CoMedis online transfer order and information service ...more

47 European reforms will speed up access to new drugs Agreement on reformed European pharmaceutical legislation was reached in the European Parliament on 17 December 2003 ...more

47 GSK's $5bn tax bill GlaxoSmithKline has been served with a claim for $2.7bn (£1.5bn) in taxes by the US for the years 1989–96. Further claims could push the bill to over $5bn ...more

47 European Court quashes Bayer's €3m PI fine The European Commission has lost its appeal against the quashing of its decision to fine Bayer €3m for restricting supplies of Adalat in Spain to try to prevent parallel importing to the UK. The European Court dismissed the appeal in a case that has been running since 1996 ...more

48 UniChem says it will maintain twice-daily pharmacy deliveries UniChem sees no need to drop its commitment to twice-daily deliveries to its community pharmacy customers unless major changes in the market require it to do so ...more

48 Debate over deodorant use and breast cancer reignited Esters of p-hydroxybenzoic acid (parabens), which are used as preservatives in underarm deodorants and antiperspirants, can be detected in samples of tissue from human breast tumours, say researchers ...more

48 More bad news for ephedra People who use dietary supplements containing ephedra and caffeine could be putting themselves at risk of developing heart problems, research suggests ...more

48 Medicine adverts appeals process clarified Rules covering the way in which pharmaceutical companies can appeal against complaints about their promotional activities have been clarified by the Prescription Medicines Code of Practice Authority ...more


R & D

49 Further evidence for efalizumab in plaque psoriasis Efalizumab, a humanised monoclonal antibody recently approved in the US for treatment of patients with chronic moderate to severe plaque psoriasis, has shown further evidence of efficacy ...more

49 Snail venom leads to effective analgesic Ziconotide, a synthetic version of a peptide found in the venom of Conus magus, a marine snail, is an effective analgesic in patients with severe chronic pain, data from two new studies indicate ...more

49 Vaccine on way for all strains of meningitis Researchers have developed an inactive form of the meningococcus bacterium that triggers an immune response against all strains of meningitis in mice ...more

49 Garlic product halts tumour Producing allicin (diallyl thiosulfinate), an active component of freshly crushed garlic, in situ can halt tumour growth, researchers from Israel have shown ...more

49 Six-pronged malaria vaccine A vaccine against malaria that contains six different parasite proteins has shown efficacy in a study conducted by researchers from the University of Oxford ...more

49 Target for jaundice treatment Researchers have shown that a component of a chinese herbal tea remedy for jaundice activates a hepatic receptor which increases clearance of bilirubin ...more

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal